Bharat Biotech : All

Covaxin

WHO’s Suspension of Covaxin Could be Hindrance for India’s Vaccine Programme

Richa Chintan

WHO

WHO Panel Recommends Emergency Use Listing Status for Covaxin: Sources

PTI

WHO

WHO to Meet Next Week to Consider Emergency Use Listing of India’s Covaxin

PTI

COVID-19: ‘If Infected Earlier, Single Covaxin Dose has Same Antibody Response as 2 Doses

COVID-19: ‘If Infected Earlier, Single Covaxin Dose has Same Antibody Response as 2 Doses

PTI

Bharat Biotech and Brazil

Partnership Fallout: Brazil Suspends Bharat Biotech's Covaxin Clinical Trials

PTI